180 Life Sciences Stock Performance
| ATNF Stock | USD 1.13 0.08 7.62% |
The firm owns a Beta (Systematic Risk) of 0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, 180 Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding 180 Life is expected to be smaller as well. At this point, 180 Life Sciences has a negative expected return of -0.5%. Please make sure to confirm 180 Life's standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if 180 Life Sciences performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days 180 Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 7 M |
180 |
180 Life Relative Risk vs. Return Landscape
If you would invest 187.00 in 180 Life Sciences on December 22, 2024 and sell it today you would lose (74.00) from holding 180 Life Sciences or give up 39.57% of portfolio value over 90 days. 180 Life Sciences is currently does not generate positive expected returns and assumes 8.8982% risk (volatility on return distribution) over the 90 days horizon. In different words, 79% of stocks are less volatile than 180, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
180 Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for 180 Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 180 Life Sciences, and traders can use it to determine the average amount a 180 Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0566
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATNF |
Estimated Market Risk
| 8.9 actual daily | 79 79% of assets are less volatile |
Expected Return
| -0.5 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average 180 Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 180 Life by adding 180 Life to a well-diversified portfolio.
180 Life Fundamentals Growth
180 Stock prices reflect investors' perceptions of the future prospects and financial health of 180 Life, and 180 Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 180 Stock performance.
| Return On Equity | -1.74 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 6.49 M | ||||
| Shares Outstanding | 3.18 M | ||||
| Price To Earning | 0.63 X | ||||
| Price To Book | 0.92 X | ||||
| EBITDA | (22.13 M) | ||||
| Cash And Equivalents | 1.63 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 1.05 M | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | 3.64 X | ||||
| Cash Flow From Operations | (10.92 M) | ||||
| Earnings Per Share | 7.98 X | ||||
| Total Asset | 5.26 M | ||||
| Retained Earnings | (127.34 M) | ||||
About 180 Life Performance
By analyzing 180 Life's fundamental ratios, stakeholders can gain valuable insights into 180 Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 180 Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 180 Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California. 180 Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.Things to note about 180 Life Sciences performance evaluation
Checking the ongoing alerts about 180 Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 180 Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 180 Life Sciences generated a negative expected return over the last 90 days | |
| 180 Life Sciences has high historical volatility and very poor performance | |
| 180 Life Sciences may become a speculative penny stock | |
| 180 Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| 180 Life Sciences currently holds 1.05 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 180 Life Sciences currently holds about 1.63 M in cash with (10.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| 180 Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 18.0% of 180 Life shares are held by company insiders |
- Analyzing 180 Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 180 Life's stock is overvalued or undervalued compared to its peers.
- Examining 180 Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 180 Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 180 Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 180 Life's stock. These opinions can provide insight into 180 Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 180 Stock analysis
When running 180 Life's price analysis, check to measure 180 Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 180 Life is operating at the current time. Most of 180 Life's value examination focuses on studying past and present price action to predict the probability of 180 Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 180 Life's price. Additionally, you may evaluate how the addition of 180 Life to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |